Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Oral contraceptives may cause hair loss in women.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

The girl's increased hair growth and other symptoms were due to a hormone-secreting ovarian tumor, which was successfully treated with surgery.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Many women in North West Saudi Arabia use herbal and home remedies for hair care, often learning about them through family and media.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Women with PCOS are more likely to experience depressive symptoms.

Women with PCOS have higher cardiometabolic risks.

Higher testosterone and lower Vitamin D levels are linked to hair loss in female COVID-19 patients.

Microbial imbalances in hair follicles may contribute to hair loss, especially in women.

Plant-derived nanoparticles from Polygoni Multiflori Radix promote hair growth better than Minoxidil by affecting androgen pathways.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.